| answer text |
<p>There are no restrictions on the type of innovation that can be supported by the
Accelerated Access Collaborative (AAC). Medicinal products, therapeutic technologies,
devices, diagnostics, and digital technologies are eligible to receive support.</p><p>In
October 2018, the AAC announced it was supporting to increased uptake and use of 12
high performing products, which span seven technology areas, in the National Health
Service. Of the seven categories selected for support, two are medicines, four are
diagnostic tests, and one is a device.</p><p>Further information about the products
the AAC are supporting can be found at the following link:</p><p><a href="https://www.nice.org.uk/aac"
target="_blank">https://www.nice.org.uk/aac</a></p>
|
 |
